20 Fanconi Anemia Clinical Trials in Indianapolis, IN (2026)

Q: How do I join a clinical trial in Indianapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you.

Recruiting Fanconi Anemia Studies in Indianapolis

NCT00063063Recruiting

Generic Database of Very Low Birth Weight Infants

The Generic Database (GDB) is a registry of very low birth weight infants born alive in NICHD Neonatal Research Network (NRN) centers. The GDB collects observational baseline data on both mothers and ...

Indianapolis, IN80,000 participantsNICHD Neonatal Research Network

View Study Details

NCT00009633Recruiting

Follow-up Visit of High Risk Infants

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, n...

Indianapolis, IN68,000 participantsNICHD Neonatal Research Network

View Study Details

NCT05934487Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure...

Indianapolis, IN1,750 participantsEndotronix, Inc.

View Study Details

NCT05656365Recruiting

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Background: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) is the most common periodic fever syndrome of childhood. Symptoms can include swelling of the glands in the...

Indianapolis, IN1,500 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05446272Recruiting

The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial

DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 23 0/7-28 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasi...

Indianapolis, IN478 participantsUniversity of Pennsylvania

View Study Details

NCT06122779Recruiting

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

The purpose of this study is to evaluate the safety, tolerability, and exposure-response (E-R) of BMS-986435/MYK-224 in participants with symptomatic Heart Failure with Preserved Ejection Fraction (HF...

Indianapolis, IN208 participantsBristol-Myers Squibb

View Study Details

NCT04862221Recruiting

TReatment for ImmUne Mediated PathopHysiology

TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will de...

Indianapolis, IN163 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT04592445Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve. The study includes peo...

Indianapolis, IN150 participantsAxon Therapies, Inc.

View Study Details

NCT07041125Recruiting

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF...

Indianapolis, IN120 participantsHeart Rhythm Clinical and Research Solutions, LLC

View Study Details

NCT06374875Recruiting

Fibrosis Lessens After Metabolic Surgery

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly associated with obesity...

Indianapolis, IN120 participantsAli Aminian

View Study Details

NCT07192952Recruiting

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Researchers are looking for a better way to treat children and young adults who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure with left ventricular systolic dysfu...

Indianapolis, IN117 participantsBayer

View Study Details

NCT07188805Recruiting

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Researchers are looking for a better way to treat children who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where the heart is unable to p...

Indianapolis, IN111 participantsBayer

View Study Details

NCT06049680Recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of parenteral nutrition treatment with SMOFlipi...

Indianapolis, IN100 participantsFresenius Kabi

View Study Details

NCT05034432Recruiting

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery...

Indianapolis, IN100 participantsUniversity of Rochester

View Study Details

NCT06753916Recruiting

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

The main objective of this study is to determine the safety of Ex Vivo Cross Linking (CXL) of donor corneal tissue in participants who have undergone high-risk penetrating keratoplasty....

Indianapolis, IN96 participantsMassachusetts Eye and Ear Infirmary

View Study Details

NCT06388226Recruiting

Leg Heat Therapy in Heart Failure With Preserved Ejection Fraction

The objective of this pilot study is to establish evidence to support the validity of HT in improving skeletal muscle function and physical capacity of patients with HFpEF. Our central hypothesis is t...

Indianapolis, IN90 participantsIndiana University

View Study Details

NCT05604131Recruiting

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorr...

Indianapolis, IN89 participantsRohan Dharmakumar

View Study Details

NCT06941870Recruiting

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

The objective of the study is to assess the improvement of synovial hypertrophy during the 12 months of efanesoctocog alfa prophylaxis once per week (QW) in joints with existing evidence of synovial h...

Indianapolis, IN35 participantsSanofi

View Study Details

NCT04567511Recruiting

Hemlibra in Mild Hemophilia A

This is a single arm, phase 4, prospective, open-label, United States single-center study to determine the hemostatic characteristics of Hemlibra (emicizumab) as measured by coagulation laboratory par...

Indianapolis, IN20 participantsIndiana Hemophilia &Thrombosis Center, Inc.

View Study Details

NCT07356843Recruiting

Palliative Care for People With HF

Imagine having heart failure, a condition where the heart struggles to pump blood, making daily life hard. People with heart failure often don't feel well and end up going to the hospital a lot. Many ...

Indianapolis, IN20 participantsIndiana University

View Study Details

About Fanconi Anemia Clinical Trials in Indianapolis

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 20 fanconi anemia clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 153,267 participants. Research is being sponsored by NICHD Neonatal Research Network, Endotronix, Inc., National Institute of Allergy and Infectious Diseases (NIAID) and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Indianapolis — FAQ

Are there fanconi anemia clinical trials in Indianapolis?

Yes, there are 20 fanconi anemia clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 20 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov